{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:32Z","timestamp":1759336472731,"version":"3.40.4"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006182","name":"fapes","doi-asserted-by":"crossref","award":["#139\/2019"],"award-info":[{"award-number":["#139\/2019"]}],"id":[{"id":"10.13039\/501100006182","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective(s):<\/jats:title>\n            <jats:p>Investigate polymorphisms and expressions of human leukocyte antigen-G (HLA-G), galectin-1 (Gal-1), and interleukin-10 (IL-10) in people living with HIV (PLHIV) with and without comorbidities to help understanding the mechanisms involved in triggering these disorders in PLHIV and in their prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Here we evaluated the potential correlation between the genetic polymorphism and\/or protein levels of HLA-G, Gal-1, and IL-10 with and without comorbidities of PLHIV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Two hundred HIV patients under antiretroviral treatment (83 with comorbidities and 117 without comorbidities) and 200 healthy individuals (controls) were genotyped, using PCR, for HLA-G 14-base pair polymorphism located at the 3\u2019 untranslated region in exon 8\u200ainsertion\/insertion (Ins\/Ins: low HLA-G expression) or deletion\/deletion (Del\/Del: high HLA-G expression). Soluble levels of HLA-G (sHLA-G), Gal-1, and IL-10 were quantified by enzyme-linked immunosorbet assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>HIV patients without comorbidities exhibited higher frequency of 14-base pair Del\/Del genotype than HIV patients with comorbidities. As expected, HIV patients Ins\/Ins with and without comorbidities produced less sHLA-G than controls. However, HIV patients Del\/Del with comorbidities expressed sHLA-G more than controls and HIV patients Del\/Del without comorbidities. Interestingly, patients that showed low levels sHLA-G, and presence of comorbidities, exhibited high Gal-1 serum levels. However, an increase in soluble levels of IL-10 in PLHIV was observed when compared to controls, especially in the PLHIV group without comorbidities suggesting, a protective role of IL-10 in the development of comorbidities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>These data suggested that the high expression of sHLA-G and IL-10 or Gal-1 could be associated and could be associated with the development or not of comorbidities in PLHIV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028489","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T13:09:12Z","timestamp":1642165752000},"page":"e28489","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Functional evaluation of immunoregulatory molecules HLA-G, galectin-1, and IL-10 in people living with HIV"],"prefix":"10.1097","volume":"101","author":[{"given":"Natalia Alves","family":"Cortelette","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Esp\u00edrito Santo, Vit\u00f3ria, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayana De Oliveira","family":"Souza","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Esp\u00edrito Santo, Vit\u00f3ria, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Cataldi-Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeir\u00e3o Preto - USP, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Arthur","sequence":"additional","affiliation":[{"name":"Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University School of Medicine, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[{"name":"Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University School of Medicine, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Dias-Baruffi","sequence":"additional","affiliation":[{"name":"Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeir\u00e3o Preto - USP, Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Amorim Melga\u00e7o","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Esp\u00edrito Santo, Vit\u00f3ria, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena Rocha","family":"Ayres","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Esp\u00edrito Santo, Vit\u00f3ria, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-1452","authenticated-orcid":false,"given":"Jo\u00e3o Alexandre","family":"Tr\u00e9s Pancoto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Esp\u00edrito Santo, Vit\u00f3ria, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bjid.2012.11.007","article-title":"Aging with HIV: a practical review","volume":"17","author":"Cardoso","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.0000042700.48769.59","article-title":"Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency","volume":"107","author":"Shlipak","year":"2003","journal-title":"Circulation"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.162.20.2333","article-title":"Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study","volume":"162","author":"Walston","year":"2002","journal-title":"Arch Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.12814","article-title":"Ageing and inflammation in patients with HIV infection","volume":"187","author":"Nasi","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"(Suppl 3)","key":"R8-20250504","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1038\/sj.gene.6364301","article-title":"Cytokine gene polymorphism in human disease: on-line databases","volume":"7","author":"Hollegaard","year":"2006","journal-title":"Genes Immun"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0966-3274(02)00061-8","article-title":"The extent and analysis of cytokine and cytokine receptor gene polymorphism","volume":"10","author":"Keen","year":"2002","journal-title":"Transpl Immunol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cyto.2004.07.014","article-title":"Cytokine genes and disease susceptibility","volume":"28","author":"Ollier","year":"2004","journal-title":"Cytokine"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association","volume":"68","author":"Donadi","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12041-013-0213-7","article-title":"Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases","volume":"92","author":"Oda","year":"2013","journal-title":"J Genet"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1007\/978-1-4939-1396-1_1","article-title":"Evolving mechanistic insights into galectin functions","volume":"1207","author":"Arthur","year":"2015","journal-title":"Methods Mol Biol"},{"key":"R14-20250504","first-page":"39","article-title":"The role of IL-10 in regulating immunity to persistent viral infections","volume":"350","author":"Wilson","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1471-4906(01)02007-5","article-title":"HLA-G: A shield against inflammatory aggression","volume":"22","author":"Carosella","year":"2001","journal-title":"Trends Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.1300438","article-title":"Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses","volume":"192","author":"Naji","year":"2014","journal-title":"J Immunol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/intimm\/13.3.385","article-title":"Maturation of antigen presenting cells is compromised in HLA-G transgenic mice","volume":"13","author":"Horuzsko","year":"2001","journal-title":"Int Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.humimm.2016.02.001","article-title":"Association of HLA-G 3\u2019 untranslated region variants with type 1 diabetes mellitus","volume":"77","author":"Albuquerque","year":"2016","journal-title":"Hum Immunol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.meegid.2014.12.021","article-title":"Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans","volume":"30","author":"Hong","year":"2015","journal-title":"Infect Genet Evol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QAD.0b013e32832027bf","article-title":"Association between HLA-G 3\u2019UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children","volume":"23","author":"Fabris","year":"2009","journal-title":"AIDS"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/tan.12296","article-title":"HLA-G 14\u200abp deletion\/insertion polymorphism and mother-to-child transmission of HIV","volume":"83","author":"Segat","year":"2014","journal-title":"Tissue Antigens"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2249.2006.03268.x","article-title":"Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis","volume":"147","author":"Donaghy","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"10784","DOI":"10.1128\/JVI.01292-10","article-title":"Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2","volume":"84","author":"Huang","year":"2010","journal-title":"J Virol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(94)90498-7","article-title":"Galectins: a family of animal beta-galactoside-binding lectins","volume":"76","author":"Barondes","year":"1994","journal-title":"Cell"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/B:MCBI.0000049376.50242.7f","article-title":"Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1\/ERK, p38 MAP kinase and p70S6 kinase","volume":"267","author":"Fuertes","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1189\/jlb.70.1.73","article-title":"Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis","volume":"70","author":"Zu\u00f1iga","year":"2001","journal-title":"J Leukoc Biol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jlb.59.3.363","article-title":"Regulated expression of a 16-kd galectin-like protein in activated rat macrophages","volume":"59","author":"Rabinovich","year":"1996","journal-title":"J Leukoc Biol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1182\/blood-2006-04-016451","article-title":"Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells","volume":"109","author":"Gar\u00edn","year":"2007","journal-title":"Blood"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2014.11.009","article-title":"Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation","volume":"27","author":"Rutkowski","year":"2015","journal-title":"Cancer Cell"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","article-title":"Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration","volume":"37","author":"Starossom","year":"2012","journal-title":"Immunity"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.1772","article-title":"Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10","volume":"10","author":"Ilarregui","year":"2009","journal-title":"Nat Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.1701172","article-title":"Galectin-1: a jack-of-all-trades in the resolution of acute and chronic inflammation","volume":"199","author":"Sundblad","year":"2017","journal-title":"J Immunol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.1128\/JVI.05351-11","article-title":"Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4","volume":"85","author":"St-Pierre","year":"2011","journal-title":"J Virol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J Exp Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly proliferation, reduce antigen-specific human T cell of, by diminishing the antigen-presenting capacity major, monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J Exp Med"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigenpresenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.gene.6364189","article-title":"Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese","volume":"6","author":"Tso","year":"2005","journal-title":"Genes Immun"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/gene.2009.9","article-title":"Extended IL10 haplotypes and their association with HIV progression to AIDS","volume":"10","author":"Oleksyk","year":"2009","journal-title":"Genes Immun"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.155.4.2222","article-title":"Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor","volume":"155","author":"Standiford","year":"1995","journal-title":"J Immunol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/0016-5085(95)90158-2","article-title":"Interleukin 10 prevents necrosis in murine experimental acute pancreatitis","volume":"108","author":"Van Laethem","year":"1995","journal-title":"Gastroenterology"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J Exp Med"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2003.11.001","article-title":"The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle","volume":"15","author":"Mocellin","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"17215","DOI":"10.1038\/s41598-018-35478-1","article-title":"HIV-1 envelope glycoproteins induce the production of TNF-\u03b1 and IL-10 in human monocytes by activating calcium pathway","volume":"8","author":"Plan\u00e8s","year":"2018","journal-title":"Sci Rep"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4049\/jimmunol.180.1.79","article-title":"HIV-1 Tat suppresses gp120-specifc T cell response in IL-10-dependent manner","volume":"180","author":"Gupta","year":"2008","journal-title":"J Immunol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1006\/cyto.2000.0741","article-title":"Monocytes are target cells for IL-10 induction by HIV-1 Nef protein","volume":"12","author":"Tangsinmankong","year":"2000","journal-title":"Cytokine"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1371\/journal.ppat.0030169","article-title":"HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells","volume":"3","author":"Shan","year":"2007","journal-title":"PLoS Pathog"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3389\/fimmu.2018.00734","article-title":"Regulatory T cells as potential targets for HIV cure research","volume":"9","author":"Kleinman","year":"2018","journal-title":"Front Immunol"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.21767\/2472-1646.100023","article-title":"HLA-G: a versatile biomarker","volume":"3","author":"Vasireddi","year":"2017","journal-title":"Biomark J"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.humimm.2003.08.347","article-title":"The 14\u200abp deletion-insertion polymorphism in the 3\u2019UT region of the HLA-G gene influences HLA-G mRNA stability","volume":"64","author":"Rousseau","year":"2003","journal-title":"Hum Immunol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/gene.2009.74","article-title":"The genetic structure of 3\u2019untraslated region of the HLA-G gene: polymorphisms and haplotypes","volume":"11","author":"Castelli","year":"2010","journal-title":"Genes Immun"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/molbev\/msr138","article-title":"A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution","volume":"28","author":"Castelli","year":"2011","journal-title":"Mol Biol Evol"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/gene.2013.67","article-title":"Worldwide genetic variation at the 3\u2019untraslated region of the HLA-G gene: balancing selection influencing genetic diversity","volume":"15","author":"Sabbagh","year":"2014","journal-title":"Genes Immun"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0039.2008.01107.x","article-title":"The 14\u200abp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma","volume":"72","author":"Chen","year":"2008","journal-title":"Tissue Antigens"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"e71742","DOI":"10.1371\/journal.pone.0071742","article-title":"Polymorphic sites at the 3\u2019 untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population","volume":"8","author":"Martelli-Palomino","year":"2013","journal-title":"PLoS One"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.humimm.2012.08.005","article-title":"Role of HLA-G 14\u200abp deletion\/insertion and +3142C\/G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis","volume":"73","author":"Rizzo","year":"2012","journal-title":"Hum Immunol"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.humimm.2009.07.028","article-title":"In silico analysis of microRNAS targeting the HLA-G 3\u2032 untranslated region alleles and haplotypes","volume":"70","author":"Castelli","year":"2009","journal-title":"Hum Immunol"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clim.2009.08.002","article-title":"Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution","volume":"133","author":"Murdaca","year":"2009","journal-title":"Clin Immunol"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.4049\/jimmunol.153.12.5782","article-title":"IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages","volume":"153","author":"Akridge","year":"1994","journal-title":"J Immunol"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/intimm\/dxh252","article-title":"HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway","volume":"17","author":"Ji","year":"2005","journal-title":"Int Immunol"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2249.1999.00865.x","article-title":"IL-10 in HIV infection: increasing serum IL-10 levels with disease progression-down-regulatory effect of potent anti-retroviral therapy","volume":"116","author":"Stylianou","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/600072","article-title":"Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis","volume":"200","author":"Naicker","year":"2009","journal-title":"J Infect Dis"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/cid\/cir811","article-title":"Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, and breadth of cytotoxic t-cell lymphocyte response during chronic HIV-1 infection","volume":"54","author":"Naicker","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cyto.2015.11.009","article-title":"Combination of low producer AA-genotypes in IFN-\u03b3 and IL-10 genes makes a high risk genetic variant for HIV disease progression","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:24:38Z","timestamp":1746332678000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028489","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"2021-07-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}